Prizes & Awards

The IAS, together with its partners, sponsors a number of scientific prizes and awards to reward promising researchers who are conducting outstanding work in HIV research.

  • Lange/van Tongeren Young Investigator Prizes – ANNUAL PRIZES
    The US$2,000 Lange/van Tongeren Young Investigator Prizes are jointly funded by the IAS and the France Recherche Nord & Sud Sida-HIV Hépatites (ANRS) to support young researchers who demonstrate innovation, originality, rationale and quality in the field of HIV research. One prize is presented to the top-scoring abstract in each of the four conference tracks. In 2015, the Young Investigator Prize was permanently renamed in memory of Joep Lange and Jacqueline van Tongeren.
    Read more
  • Lange/van Tongeren HIV Cure Young Investigator Award – ANNUAL AWARD
    The US$2,000 Lange/van Tongeren HIV Cure Young Investigator Award is jointly funded by the IAS and the France Recherche Nord & Sud Sida-HIV Hépatites (ANRS) to support young researchers who demonstrate innovation, originality, rationale and quality in the field of HIV cure and remission research. One award is presented to the top-scoring abstract from relevant track categories related to HIV cure and remission research.
    Read more
  • Women, Girls and HIV Investigator’s Prize – ANNUAL PRIZE
    The vulnerability of women and girls to HIV infection and accelerated disease progression is well-documented. As HIV incidence continues to increase among women and girls, particularly in resource-limited settings, research on gender-related issues, including community-based interventions and investigations, will provide critical evidence and information on which to base our response. One prize is presented to the top-scoring abstract, which encourages research in low- or middle-income countries that can benefit women and girls affected by HIV and AIDS.
    Read more
  • IAS TB/HIV Research Prizes – ANNUAL PRIZES
    The two US$1,000 IAS TB/HIV Research Prizes are incentives for young and established researchers to investigate pertinent research questions that affect TB/HIV co-infection and operational effectiveness of implementing core TB/HIV collaborative services. The prizes are presented to the two top-scoring abstracts in any of these areas.
    Read more